Peijia Medical Limited reported unaudited consolidated earnings results for the six months ended June 30, 2020. For the period, the company reported revenue was RMB 14,239,000 against RMB 5,239,000 a year ago. Operating loss was RMB 98,328,000 against RMB 43,230,000 a year ago. Loss for the period was RMB 1,788,926,000 or RMB 8.68 per basic and diluted share against RMB 133,590,000 or RMB 12.04 cents per basic and diluted share a year ago.